PATENT CLAIM ANALYSIS

Application Number: 16068845
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "187100"]

Abstract:
The present invention relates to pharmaceutical composition and uses thereof for restoring T-cell lymphopoiesis in subjects infected with human immunodeficiency virus (HIV). In particular, the present invention relates to a P2X7 receptor antagonist for use in a method of restoring T-cell lymphopoiesis in a subject infected with human immunodeficiency virus (HIV) comprising administering to the subject a therapeutically effective amount of said P2X7 receptor antagonist.

Claim (Index 1):
A method of restoring T-cell lymphopoiesis in a subject infected with human immunodeficiency virus (HIV) comprising administering to the subject a therapeutically effective amount of a P2X7 receptor antagonist.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 95.0
- Lexical Diversity: 1.67442
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14532476', '12558111', '13063400', '09428458', '14808860']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6599694285374064
- 35 USC 102 Novelty (BERT): 0.4975988284329946
- Combined Prediction Score: 0.6437323685269652
- Mean Citation Score: 181.693884
- Max Citation Score: 185.58426
- Similarity Product: 122.09013914459108

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test